Manohar Jha
Physician at King George's Medical University, Lucknow
Data updated
Papers
Trials
Research Footprint
Manohar Jha appears in 5 tracked papers (2021–2024), most studied alongside Ketamine, Esketamine and Placebo, across Depressive Disorders, Major Depressive Disorder (MDD) and PTSD.
Most-cited paper: A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder (232 citations).
Frequent co-authors: James Murrough, Dennis Charney and Kate Collins.
Background & Research
Manohar K. Jha appears as an author on several psychiatric and neurobiological studies involving ketamine and esketamine, including randomized and real-world clinical research in PTSD, suicidality, and treatment-resistant depression. A recent PubMed-indexed paper lists him as affiliated with King George's Medical University in Lucknow, India. ([colab.ws](https://colab.ws/articles/10.1176%2Fappi.focus.23021014?utm_source=openai))
Key Impact
He is a coauthor on multiple clinical ketamine and esketamine studies spanning PTSD, depression, suicidality, and neuroimaging, indicating a meaningful role in psychedelic/rapid-acting antidepressant research.
Collaboration Network
14 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Manohar Jha is associated with.
King George's Medical University, Lucknow, India
King George's Medical University (KGMU) is a public medical university and large teaching hospital in Lucknow, Uttar Pradesh, India, established in 1905; it offers undergraduate, postgraduate and research programs in medicine, dentistry, nursing and allied health sciences.
View stakeholder →Baylor College of Medicine
Academic medical center in Houston affiliated with multiple Texas Medical Center hospitals. Conducts psilocybin and MDMA clinical trials for veteran PTSD in partnership with the Michael E. DeBakey VA, and houses the ELIPSIS program — a dedicated initiative on the ethical and legal implications of psychedelics in society.
View stakeholder →